News & Events about Crispr Therapeutics Ag.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
In researching this article, we used AI to help make predictions for potential triple-digit return biotech stocks by 2025
The post 3 Biotech Stocks That AI Predicts Will Deliver Triple-Digit Returns in 2025 appeared first on ...
ZUG, Switzerland and CAMBRIDGE, Mass., June 13, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) today announced that both pivotal trials for exagamglogene autotemcel (exa-cel) in patients with transfusion-dependent beta thalassemia (TDT) or severe sickle cell disease (SCD) met primary and key secondary...
The FDA has accepted the application forVertex Pharmaceuticals IncorporatedandCRISPR Therapeutics AG(NASDAQ: CRSP) exa-cel for sickle cell disease and transfusion-dependent
Latest Ratings for CRSP
DateFirmActionFromTo Feb 2022RBC CapitalMaintainsSector Perform Feb 2022SVB ...
BRENTWOOD, TN / ACCESSWIRE / April 11, 2023 / The global biotechnology industry was worth $859 billion in 2022, and it is predicted to reach $1.6 trillion by 2030, growing at a compound annual growth rate (CAGR) of 8.7% over the forecast period.A burgeoning sector within biotech is the cell...